Flaskworks Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Employees
-
4
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$4.3M
Flaskworks General Information
Description
Developor of life-saving immunotherapeutics intended for cancer and other diseases. The company's technology manufactures dendritic cells and develops modular, closed, and disposable systems that address the bottlenecks of therapies, thereby enabling physicians to treat patients successfully and more effectively.
Contact Information
Website
www.flaskworks.comCorporate Office
- 38 Wareham Street
- 3rd Floor
- Boston, MA 02118
- United States
Corporate Office
- 38 Wareham Street
- 3rd Floor
- Boston, MA 02118
- United States
Flaskworks Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 28-Aug-2020 | $4.3M | Completed | Startup | ||
| 2. Angel (individual) | 29-Oct-2018 | Completed | Startup | |||
| 1. Grant | 01-Jan-2018 | $225K | Completed | Startup |
Flaskworks Comparisons
Industry
Financing
Details
Flaskworks Competitors (22)
One of Flaskworks’s 22 competitors is Centrose, a Venture Capital-Backed company based in Madison, WI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Centrose | Venture Capital-Backed | Madison, WI | ||||
| Noveome Biotherapeutics | Venture Capital-Backed | Pittsburgh, PA | ||||
| Iovance Biotherapeutics | Corporation | San Carlos, CA | ||||
| Autolus | Formerly VC-backed | London, United Kingdom | ||||
| TScan Therapeutics | Formerly VC-backed | Waltham, MA |
Flaskworks Patents
Flaskworks Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024383134-A1 | Processing instrument for cellular therapy manufacturing | Pending | 15-Nov-2023 | ||
| EP-4809065-A1 | Processing instrument for cellular therapy manufacturing | Pending | 15-Nov-2023 | ||
| WO-2025106534-A1 | Processing instrument for cellular therapy manufacturing | Inactive | 15-Nov-2023 | ||
| AU-2023398812-A1 | Method for collecting cell types | Pending | 16-Dec-2022 | ||
| EP-4633762-A1 | Method for collecting cell types | Pending | 16-Dec-2022 | A61M1/3693 |
Flaskworks Signals
Flaskworks Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| US National Science Foundation | Accelerator/Incubator |
Flaskworks FAQs
-
When was Flaskworks founded?
Flaskworks was founded in 2016.
-
Where is Flaskworks headquartered?
Flaskworks is headquartered in Boston, MA.
-
What is the size of Flaskworks?
Flaskworks has 4 total employees.
-
What industry is Flaskworks in?
Flaskworks’s primary industry is Other Devices and Supplies.
-
Is Flaskworks a private or public company?
Flaskworks is a Private company.
-
What is the current valuation of Flaskworks?
The current valuation of Flaskworks is .
-
What is Flaskworks’s current revenue?
The current revenue for Flaskworks is .
-
How much funding has Flaskworks raised over time?
Flaskworks has raised $750K.
-
Who are Flaskworks’s investors?
US National Science Foundation has invested in Flaskworks.
-
Who are Flaskworks’s competitors?
Centrose, Noveome Biotherapeutics, Iovance Biotherapeutics, Autolus, and TScan Therapeutics are some of the 22 competitors of Flaskworks.
-
When was Flaskworks acquired?
Flaskworks was acquired on 28-Aug-2020.
-
Who acquired Flaskworks?
Flaskworks was acquired by Northwest Biotherapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process